{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:37:57Z","timestamp":1787002677416,"version":"build-2736575974"},"reference-count":103,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T00:00:00Z","timestamp":1743379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T00:00:00Z","timestamp":1743379200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Hypertens"],"DOI":"10.1038\/s41371-025-01013-9","type":"journal-article","created":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T13:08:40Z","timestamp":1743512920000},"page":"320-333","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["A salty symphony: unraveling the tale of uromodulin and sodium sensitivity"],"prefix":"10.1038","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7054-1422","authenticated-orcid":false,"given":"Artemios G.","family":"Karagiannidis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6216-9635","authenticated-orcid":false,"given":"Marieta P.","family":"Theodorakopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8863-227X","authenticated-orcid":false,"given":"Fotini","family":"Iatridi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9805-9523","authenticated-orcid":false,"given":"Alberto","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9174-4018","authenticated-orcid":false,"given":"Pantelis","family":"Sarafidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,31]]},"reference":[{"key":"1013_CR1","doi-asserted-by":"crossref","DOI":"10.1093\/ndt\/gfae008","volume":"39","author":"AG Karagiannidis","year":"2024","unstructured":"Karagiannidis AG, Theodorakopoulou MP, Pella E, Sarafidis PA, Ortiz A. Uromodulin biology. Nephrol Dial Transplant. 2024;39:gfae008.","journal-title":"Nephrol Dial Transplant"},{"key":"1013_CR2","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1161\/HYPERTENSIONAHA.122.18567","volume":"79","author":"KA LaFavers","year":"2022","unstructured":"LaFavers KA, Micanovic R, Sabo AR, Maghak LA, El-Achkar TM. Evolving concepts in uromodulin biology, physiology, and its role in disease: a tale of two forms. Hypertension. 2022;79:2409\u201318.","journal-title":"Hypertension"},{"key":"1013_CR3","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1042\/bj2270957","volume":"227","author":"JS Hunt","year":"1985","unstructured":"Hunt JS, McGiven AR, Groufsky A, Lynn KL, Taylor MC. Affinity-purified antibodies of defined specificity for use in a solid-phase microplate radioimmunoassay of human Tamm-Horsfall glycoprotein in urine. Biochem J. 1985;227:957\u201363.","journal-title":"Biochem J"},{"key":"1013_CR4","first-page":"303","volume":"2a","author":"C Rovida","year":"1873","unstructured":"Rovida C. Conclusione degli studi intorno all\u2019origine istologica dei cilindri dell\u2019urina. Riv Clin Bologna. 1873;2a:303\u20136.","journal-title":"Riv Clin Bologna"},{"key":"1013_CR5","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3181\/00379727-74-17825","volume":"74","author":"I Tamm","year":"1950","unstructured":"Tamm I, Horsfall FL. Characterization and separation of an inhibitor of viral hemagglutination present in urine. Proc Soc Exp Biol Med. 1950;74:106\u20138.","journal-title":"Proc Soc Exp Biol Med"},{"key":"1013_CR6","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1126\/science.2409603","volume":"229","author":"AV Muchmore","year":"1985","unstructured":"Muchmore AV, Decker JM. Uromodulin: a unique 85-Kilodalton immunosuppressive glycoprotein isolated from urine of pregnant women. Science. 1985;229:479\u201381.","journal-title":"Science"},{"key":"1013_CR7","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1600-0897.1986.tb00037.x","volume":"11","author":"AV Muchmore","year":"1986","unstructured":"Muchmore AV. Uromodulin: an immunoregulatory glycoprotein isolated from pregnancy urine that binds to and regulates the activity of interleukin 1. Am J Reprod Immunol Microbiol. 1986;11:89\u201393.","journal-title":"Am J Reprod Immunol Microbiol"},{"key":"1013_CR8","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1126\/science.3453112","volume":"236","author":"D Pennica","year":"1987","unstructured":"Pennica D, Kohr WJ, Kuang WJ, Glaister D, Aggarwal BB, Chen EY, et al. Identification of human uromodulin as the tamm-horsfall urinary glycoprotein. Science. 1987;236:83\u20138.","journal-title":"Science"},{"key":"1013_CR9","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1038\/ki.1990.128","volume":"37","author":"S Kumar","year":"1990","unstructured":"Kumar S, Muchmore A. Tamm-Horsfall protein-uromodulin (1950\u20131990). Kidney Int. 1990;37:1395\u2013401.","journal-title":"Kidney Int"},{"key":"1013_CR10","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s11255-023-03664-4","volume":"56","author":"G Sun","year":"2024","unstructured":"Sun G, Liu C, Song C, Geng X, Chi K, Fu Z, et al. Knowledge mapping of UMOD of English published work from 1985 to 2022: a bibliometric analysis. Int Urol Nephrol. 2024;56:249\u201361.","journal-title":"Int Urol Nephrol"},{"key":"1013_CR11","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nrneph.2017.101","volume":"13","author":"O Devuyst","year":"2017","unstructured":"Devuyst O, Olinger E, Rampoldi L. Uromodulin: from physiology to rare and complex kidney disorders. Nat Rev Nephrol. 2017;13:525\u201344.","journal-title":"Nat Rev Nephrol"},{"key":"1013_CR12","doi-asserted-by":"crossref","first-page":"150","DOI":"10.2215\/CJN.06390420","volume":"16","author":"A Kipp","year":"2021","unstructured":"Kipp A, Olinger E. What does uromodulin do? Clin J Am Soc Nephrol. 2021;16:150\u20133.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1013_CR13","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/s41581-024-00881-7","volume":"20","author":"A Nanamatsu","year":"2024","unstructured":"Nanamatsu A, De Ara\u00fajo L, LaFavers KA, El-Achkar TM. Advances in uromodulin biology and potential clinical applications. Nat Rev Nephrol. 2024;20:806\u201321.","journal-title":"Nat Rev Nephrol"},{"key":"1013_CR14","doi-asserted-by":"crossref","first-page":"F403","DOI":"10.1152\/ajprenal.00322.2021","volume":"322","author":"R Micanovic","year":"2022","unstructured":"Micanovic R, LaFavers KA, Patidar KR, Ghabril MS, Doud EH, Mosley AL, et al. The kidney releases a nonpolymerizing form of uromodulin in the urine and circulation that retains the external hydrophobic patch domain. Am J Physiol Renal Physiol. 2022;322:F403\u201318.","journal-title":"Am J Physiol Renal Physiol"},{"key":"1013_CR15","doi-asserted-by":"crossref","first-page":"F559","DOI":"10.1152\/ajprenal.00143.2004","volume":"288","author":"S Bachmann","year":"2005","unstructured":"Bachmann S, Mutig K, Bates J, Welker P, Geist B, Gross V, et al. Renal effects of Tamm-Horsfall protein (uromodulin) deficiency in mice. Am J Physiol Renal Physiol. 2005;288:F559\u201367.","journal-title":"Am J Physiol Renal Physiol"},{"key":"1013_CR16","doi-asserted-by":"crossref","first-page":"30200","DOI":"10.1074\/jbc.M111.222968","volume":"286","author":"K Mutig","year":"2011","unstructured":"Mutig K, Kahl T, Saritas T, Godes M, Persson P, Bates J, et al. Activation of the bumetanide-sensitive Na+, K+, 2Cl- cotransporter (NKCC2) is facilitated by Tamm-Horsfall protein in a chloride-sensitive manner. J Biol Chem. 2011;286:30200\u201310.","journal-title":"J Biol Chem"},{"key":"1013_CR17","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1038\/nm.3384","volume":"19","author":"M Trudu","year":"2013","unstructured":"Trudu M, Janas S, Lanzani C, Debaix H, Schaeffer C, Ikehata M, et al. Common noncoding UMOD gene variants induce salt-sensitive hypertension and kidney damage by increasing uromodulin expression. Nat Med. 2013;19:1655\u201360.","journal-title":"Nat Med"},{"key":"1013_CR18","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.kint.2018.04.021","volume":"94","author":"N Tokonami","year":"2018","unstructured":"Tokonami N, Takata T, Beyeler J, Ehrbar I, Yoshifuji A, Christensen EI, et al. Uromodulin is expressed in the distal convoluted tubule, where it is critical for regulation of the sodium chloride cotransporter NCC. Kidney Int. 2018;94:701\u201315.","journal-title":"Kidney Int"},{"key":"1013_CR19","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/ki.2013.63","volume":"84","author":"MTF Wolf","year":"2013","unstructured":"Wolf MTF, Wu XR, Huang CL. Uromodulin upregulates TRPV5 by impairing caveolin-mediated endocytosis. Kidney Int. 2013;84:130\u20137.","journal-title":"Kidney Int"},{"key":"1013_CR20","doi-asserted-by":"crossref","first-page":"16488","DOI":"10.1074\/jbc.RA118.003950","volume":"293","author":"M Nie","year":"2018","unstructured":"Nie M, Bal MS, Liu J, Yang Z, Rivera C, Wu XR, et al. Uromodulin regulates renal magnesium homeostasis through the ion channel transient receptor potential melastatin 6 (TRPM6). J Biol Chem. 2018;293:16488\u2013502.","journal-title":"J Biol Chem"},{"key":"1013_CR21","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1111\/j.1523-1755.2004.00867.x","volume":"66","author":"L Mo","year":"2004","unstructured":"Mo L, Huang HY, Zhu XH, Shapiro E, Hasty DL, Wu XR. Tamm-Horsfall protein is a critical renal defense factor protecting against calcium oxalate crystal formation. Kidney Int. 2004;66:1159\u201366.","journal-title":"Kidney Int"},{"key":"1013_CR22","doi-asserted-by":"crossref","first-page":"9924","DOI":"10.1074\/jbc.M008610200","volume":"276","author":"J Pak","year":"2001","unstructured":"Pak J, Pu Y, Zhang ZT, Hasty DL, Wu XR. Tamm-Horsfall protein binds to type 1 fimbriated Escherichia coli and prevents E. coli from binding to uroplakin Ia and Ib receptors. J Biol Chem. 2001;276:9924\u201330.","journal-title":"J Biol Chem"},{"key":"1013_CR23","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1523-1755.2004.00452.x","volume":"65","author":"JM Bates","year":"2004","unstructured":"Bates JM, Raffi HM, Prasadan K, Mascarenhas R, Laszik Z, Maeda N, et al. Tamm-Horsfall protein knockout mice are more prone to urinary tract infection: rapid communication. Kidney Int. 2004;65:791\u20137.","journal-title":"Kidney Int"},{"key":"1013_CR24","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1053\/j.ajkd.2016.08.022","volume":"69","author":"PS Garimella","year":"2017","unstructured":"Garimella PS, Bartz TM, Ix JH, Chonchol M, Shlipak MG, Devarajan P, et al. Urinary uromodulin and risk of urinary tract infections: The Cardiovascular Health Study. Am J Kidney Dis. 2017;69:744\u201351.","journal-title":"Am J Kidney Dis"},{"key":"1013_CR25","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1172\/JCI200522720","volume":"115","author":"MD S\u00e4emann","year":"2005","unstructured":"S\u00e4emann MD, Weichhart T, Zeyda M, Staffler G, Schunn M, Stuhlmeier KM, et al. Tamm-horsfall glycoprotein links innate immune cell activation with adaptive immunity via a Toll-like receptor-4\u2013dependent mechanism. J Clin Invest. 2005;115:468\u201375.","journal-title":"J Clin Invest"},{"key":"1013_CR26","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1681\/ASN.2012040338","volume":"23","author":"MN Darisipudi","year":"2012","unstructured":"Darisipudi MN, Thomasova D, Mulay SR, Brech D, Noessner E, Liapis H, et al. Uromodulin triggers IL-1\u03b2\u2013dependent innate immunity via the NLRP3 inflammasome. J Am Soc Nephrol. 2012;23:1783\u20139.","journal-title":"J Am Soc Nephrol"},{"key":"1013_CR27","doi-asserted-by":"crossref","first-page":"F212","DOI":"10.1152\/ajprenal.00146.2022","volume":"323","author":"KA LaFavers","year":"2022","unstructured":"LaFavers KA, Hage CA, Gaur V, Micanovic R, Hato T, Khan S, et al. The kidney protects against sepsis by producing systemic uromodulin. Am J Physiol Renal Physiol. 2022;323:F212\u201326.","journal-title":"Am J Physiol Renal Physiol"},{"key":"1013_CR28","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaw3639","volume":"11","author":"KA LaFavers","year":"2019","unstructured":"LaFavers KA, Macedo E, Garimella PS, Lima C, Khan S, Myslinski J, et al. Circulating uromodulin inhibits systemic oxidative stress by inactivating the TRPM2 channel. Sci Transl Med. 2019;11:eaaw3639.","journal-title":"Sci Transl Med"},{"key":"1013_CR29","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1093\/cvr\/cvaa081","volume":"117","author":"I Alesutan","year":"2021","unstructured":"Alesutan I, Luong TTD, Schelski N, Masyout J, Hille S, Schneider MP, et al. Circulating uromodulin inhibits vascular calcification by interfering with pro-inflammatory cytokine signalling. Cardiovasc Res. 2021;117:930\u201341.","journal-title":"Cardiovasc Res"},{"key":"1013_CR30","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1053\/j.ajkd.2019.02.024","volume":"74","author":"D Steubl","year":"2019","unstructured":"Steubl D, Buzkova P, Garimella PS, Ix JH, Devarajan P, Bennett MR, et al. Association of serum uromodulin with ESKD and kidney function decline in the elderly: The Cardiovascular Health Study. Am J Kidney Dis. 2019;74:501\u20139.","journal-title":"Am J Kidney Dis"},{"key":"1013_CR31","doi-asserted-by":"crossref","first-page":"616","DOI":"10.2215\/CJN.11780919","volume":"15","author":"D Steubl","year":"2020","unstructured":"Steubl D, Schneider MP, Meiselbach H, Nadal J, Schmid MC, Saritas T, et al. Association of serum uromodulin with death, cardiovascular events, and kidney failure in CKD. Clin J Am Soc Nephrol. 2020 May;15:616\u201324.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1013_CR32","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1093\/ndt\/gfz008","volume":"35","author":"D Steubl","year":"2020","unstructured":"Steubl D, Buzkova P, Garimella PS, Ix JH, Devarajan P, Bennett MR, et al. Association of serum uromodulin with mortality and cardiovascular disease in the elderly\u2014the Cardiovascular Health Study. Nephrol Dial Transplant. 2020;35:1399\u2013405.","journal-title":"Nephrol Dial Transplant"},{"key":"1013_CR33","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1136\/jmg.39.12.882","volume":"39","author":"TC Hart","year":"2002","unstructured":"Hart TC. Mutations of the UMOD gene are responsible for medullary cystic kidney disease 2 and familial juvenile hyperuricaemic nephropathy. J Med Genet. 2002;39:882\u201392.","journal-title":"J Med Genet"},{"key":"1013_CR34","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1681\/ASN.2017070716","volume":"29","author":"O Devuyst","year":"2018","unstructured":"Devuyst O, Pattaro C. The UMOD locus: insights into the pathogenesis and prognosis of kidney disease. J Am Soc Nephrol. 2018;29:713\u201326.","journal-title":"J Am Soc Nephrol"},{"key":"1013_CR35","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s00424-022-02733-4","volume":"474","author":"O Devuyst","year":"2022","unstructured":"Devuyst O, Bochud M, Olinger E. UMOD and the architecture of kidney disease. Pflugers Arch. 2022;474:771\u201381.","journal-title":"Pflugers Arch"},{"key":"1013_CR36","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/ng.568","volume":"42","author":"A K\u00f6ttgen","year":"2010","unstructured":"K\u00f6ttgen A, Pattaro C, B\u00f6ger CA, Fuchsberger C, Olden M, Glazer NL, et al. New loci associated with kidney function and chronic kidney disease. Nat Genet. 2010;42:376\u201384.","journal-title":"Nat Genet"},{"key":"1013_CR37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1001177","volume":"6","author":"S Padmanabhan","year":"2010","unstructured":"Padmanabhan S, Melander O, Johnson T, Di Blasio AM, Lee WK, Gentilini D, et al. Genome-Wide Association Study of blood pressure extremes identifies variant near UMOD associated with hypertension. PLoS Genet. 2010;6:e1001177.","journal-title":"PLoS Genet"},{"key":"1013_CR38","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1161\/HYP.0000000000000047","volume":"68","author":"F Elijovich","year":"2016","unstructured":"Elijovich F, Weinberger MH, Anderson CAM, Appel LJ, Bursztyn M, Cook NR, et al. Salt sensitivity of blood pressure: a scientific statement from The American Heart Association. Hypertension. 2016;68:e7\u201346.","journal-title":"Hypertension"},{"key":"1013_CR39","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1056\/NEJMra1212606","volume":"368","author":"TA Kotchen","year":"2013","unstructured":"Kotchen TA, Cowley AW, Frohlich ED. Salt in health and disease-a delicate balance. N Engl J Med. 2013;368:1229\u201337.","journal-title":"N Engl J Med"},{"key":"1013_CR40","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.005653","volume":"6","author":"TW Kurtz","year":"2017","unstructured":"Kurtz TW, DiCarlo SE, Pravenec M, Morris RC. An appraisal of methods recently recommended for testing salt sensitivity of blood pressure. JAHA. 2017;6:e005653.","journal-title":"JAHA"},{"key":"1013_CR41","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003736","volume":"5","author":"P Castiglioni","year":"2016","unstructured":"Castiglioni P, Parati G, Lazzeroni D, Bini M, Faini A, Brambilla L, et al. Hemodynamic and autonomic response to different salt intakes in normotensive individuals. J Am Heart Assoc. 2016;5:e003736.","journal-title":"J Am Heart Assoc"},{"key":"1013_CR42","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s11906-022-01201-9","volume":"24","author":"RA Felder","year":"2022","unstructured":"Felder RA, Gildea JJ, Xu P, Yue W, Armando I, Carey RM, et al. Inverse salt sensitivity of blood pressure: mechanisms and potential relevance for prevention of cardiovascular disease. Curr Hypertens Rep. 2022;24:361\u201374.","journal-title":"Curr Hypertens Rep"},{"key":"1013_CR43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/01.HYP.10.1.1","volume":"10","author":"AC Guyton","year":"1987","unstructured":"Guyton AC. Renal function curve-a key to understanding the pathogenesis of hypertension. Hypertension. 1987;10:1\u20136.","journal-title":"Hypertension"},{"key":"1013_CR44","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/s41371-020-00407-1","volume":"35","author":"O Balafa","year":"2021","unstructured":"Balafa O, Kalaitzidis RG. Salt sensitivity and hypertension. J Hum Hypertens. 2021;35:184\u201392.","journal-title":"J Hum Hypertens"},{"key":"1013_CR45","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1161\/01.HYP.32.5.820","volume":"32","author":"FJ He","year":"1998","unstructured":"He FJ, Markandu ND, Sagnella GA, MacGregor GA. Importance of the renin system in determining blood pressure fall with salt restriction in black and white hypertensives. Hypertension. 1998;32:820\u20134.","journal-title":"Hypertension"},{"key":"1013_CR46","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1161\/01.HYP.38.3.321","volume":"38","author":"FJ He","year":"2001","unstructured":"He FJ, Markandu ND, MacGregor GA. Importance of the renin system for determining blood pressure fall with acute salt restriction in hypertensive and normotensive whites. Hypertension. 2001;38:321\u20135.","journal-title":"Hypertension"},{"key":"1013_CR47","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3945\/ajcn.2009.29028","volume":"92","author":"MS Yatabe","year":"2010","unstructured":"Yatabe MS, Yatabe J, Yoneda M, Watanabe T, Otsuki M, Felder RA, et al. Salt sensitivity is associated with insulin resistance, sympathetic overactivity, and decreased suppression of circulating renin activity in lean patients with essential hypertension. Am J Clin Nutr. 2010;92:77\u201382.","journal-title":"Am J Clin Nutr"},{"key":"1013_CR48","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/ki.1994.264","volume":"46","author":"JP Tolins","year":"1994","unstructured":"Tolins JP, Shultz PJ. Endogenous nitric oxide synthesis determines sensitivity to the pressor effect of salt. Kidney Int. 1994;46:230\u20136.","journal-title":"Kidney Int"},{"key":"1013_CR49","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/ki.1994.333","volume":"46","author":"C Ferri","year":"1994","unstructured":"Ferri C, Bellini C, Carlomagno A, Perrone A, Santucci A. Urinary kallikrein and salt sensitivity in essential hypertensive males. Kidney Int. 1994;46:780\u20138.","journal-title":"Kidney Int"},{"key":"1013_CR50","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/ki.1982.32","volume":"21","author":"VM Campese","year":"1982","unstructured":"Campese VM, Romoff MS, Levitan D, Saglikes Y, Friedler RM, Massry SG. Abnormal relationship between sodium intake and sympathetic nervous system activity in salt-sensitive patients with essential hypertension. Kidney Int. 1982;21:371\u20138.","journal-title":"Kidney Int"},{"key":"1013_CR51","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1161\/01.HYP.28.3.335","volume":"28","author":"VM Campese","year":"1996","unstructured":"Campese VM, Tawadrous M, Bigazzi R, Bianchi S, Mann AS, Oparil S, et al. Salt Intake and Plasma Atrial Natriuretic Peptide and Nitric Oxide in Hypertension. Hypertension. 1996;28:335\u201340.","journal-title":"Hypertension"},{"key":"1013_CR52","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1161\/01.HYP.0000202480.06735.82","volume":"47","author":"CL Laffer","year":"2006","unstructured":"Laffer CL, Bolterman RJ, Romero JC, Elijovich F. Effect of Salt on Isoprostanes in Salt-Sensitive Essential Hypertension. Hypertension. 2006;47:434\u201340.","journal-title":"Hypertension"},{"key":"1013_CR53","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/1470320312454764","volume":"14","author":"M Imanishi","year":"2013","unstructured":"Imanishi M, Okada N, Konishi Y, Morikawa T, Maeda I, Kitabayashi C, et al. Angiotensin II receptor blockade reduces salt sensitivity of blood pressure through restoration of renal nitric oxide synthesis in patients with diabetic nephropathy. J Renin Angiotensin Aldosterone Syst. 2013;14:67\u201373.","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"1013_CR54","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000098955","volume":"27","author":"PA Sarafidis","year":"2007","unstructured":"Sarafidis PA, Bakris GL. The antinatriuretic effect of insulin: an unappreciated mechanism for hypertension associated with insulin resistance? Am J Nephrol. 2007;27:44\u201354.","journal-title":"Am J Nephrol"},{"key":"1013_CR55","doi-asserted-by":"crossref","first-page":"H203","DOI":"10.1152\/ajpheart.01237.2003","volume":"287","author":"J Titze","year":"2004","unstructured":"Titze J, Shakibaei M, Schafflhuber M, Schulze-Tanzil G, Porst M, Schwind KH, et al. Glycosaminoglycan polymerization may enable osmotically inactive Na+ storage in the skin. Am J Physiol Heart Circ Physiol. 2004;287:H203\u20138.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1013_CR56","doi-asserted-by":"crossref","first-page":"7","DOI":"10.5049\/EBP.2015.13.1.7","volume":"13","author":"HY Choi","year":"2015","unstructured":"Choi HY, Park HC, Ha SK. Salt sensitivity and hypertension: a paradigm shift from kidney malfunction to vascular endothelial dysfunction. Electrolyte Blood Press. 2015;13:7.","journal-title":"Electrolyte Blood Press"},{"key":"1013_CR57","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1159\/000529057","volume":"53","author":"WW Parksook","year":"2022","unstructured":"Parksook WW, Williams GH. Challenges and approach to identifying individuals with salt sensitivity of blood pressure. Am J Nephrol. 2022;53:847\u201355.","journal-title":"Am J Nephrol"},{"key":"1013_CR58","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1161\/HYPERTENSIONAHA.123.17959","volume":"81","author":"MA Bailey","year":"2024","unstructured":"Bailey MA, Dhaun N. Salt sensitivity: causes, consequences, and recent advances. Hypertension. 2024;81:476\u201389.","journal-title":"Hypertension"},{"key":"1013_CR59","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1161\/HYPERTENSIONAHA.113.01831","volume":"62","author":"PW De Leeuw","year":"2013","unstructured":"De Leeuw PW, Kroon AA. Salt and sensitivity. Hypertension. 2013;62:461\u20132.","journal-title":"Hypertension"},{"key":"1013_CR60","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1097\/HJH.0000000000002861","volume":"39","author":"P Boder","year":"2021","unstructured":"Boder P, Mary S, Mark PB, Leiper J, Dominiczak AF, Padmanabhan S, et al. Mechanistic interactions of uromodulin with the thick ascending limb: perspectives in physiology and hypertension. J Hypertens. 2021;39:1490\u2013504.","journal-title":"J Hypertens"},{"key":"1013_CR61","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.cmet.2011.07.009","volume":"14","author":"JA McCormick","year":"2011","unstructured":"McCormick JA, Mutig K, Nelson JH, Saritas T, Hoorn EJ, Yang CL, et al. A SPAK isoform switch modulates renal salt transport and blood pressure. Cell Metab. 2011;14:352\u201364.","journal-title":"Cell Metab"},{"key":"1013_CR62","doi-asserted-by":"crossref","first-page":"5418","DOI":"10.1016\/S0021-9258(18)60733-1","volume":"263","author":"AP Sherblom","year":"1988","unstructured":"Sherblom AP, Decker JM, Muchmore AV. The lectin-like interaction between recombinant tumor necrosis factor and uromodulin. J Biol Chem. 1988;263:5418\u201324.","journal-title":"J Biol Chem"},{"key":"1013_CR63","doi-asserted-by":"crossref","first-page":"F94","DOI":"10.1152\/ajprenal.00650.2010","volume":"301","author":"S Battula","year":"2011","unstructured":"Battula S, Hao S, Pedraza PL, Stier CT, Ferreri NR. Tumor necrosis factor-\u03b1 is an endogenous inhibitor of Na + -K + -2Cl\u2212 cotransporter (NKCC2) isoform A in the thick ascending limb. Am J Physiol Renal Physiol. 2011;301:F94\u2013100.","journal-title":"Am J Physiol Renal Physiol"},{"key":"1013_CR64","doi-asserted-by":"crossref","first-page":"F273","DOI":"10.1152\/ajprenal.00388.2019","volume":"318","author":"S Hao","year":"2020","unstructured":"Hao S, Salzo J, Hao M, Ferreri NR. Regulation of NKCC2B by TNF-\u03b1 in response to salt restriction. Am J Physiol Renal Physiol. 2020;318:F273\u201382.","journal-title":"Am J Physiol Renal Physiol"},{"key":"1013_CR65","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1161\/HYPERTENSIONAHA.122.19888","volume":"79","author":"S Mary","year":"2022","unstructured":"Mary S, Boder P, Padmanabhan S, McBride MW, Graham D, Delles C, et al. Role of uromodulin in salt-sensitive hypertension. Hypertension. 2022;79:2419\u201329.","journal-title":"Hypertension"},{"key":"1013_CR66","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/ndt\/gfu365","volume":"30","author":"M Zacchia","year":"2015","unstructured":"Zacchia M, Capasso G. The importance of uromodulin as regulator of salt reabsorption along the thick ascending limb. Nephrol Dial Transplant. 2015;30:158\u201360.","journal-title":"Nephrol Dial Transplant"},{"key":"1013_CR67","doi-asserted-by":"crossref","first-page":"F1062","DOI":"10.1152\/ajprenal.00233.2017","volume":"314","author":"Y Liu","year":"2018","unstructured":"Liu Y, Goldfarb DS, El-Achkar TM, Lieske JC, Wu XR. Tamm-Horsfall protein\/uromodulin deficiency elicits tubular compensatory responses leading to hypertension and hyperuricemia. Am J Physiol Renal Physiol. 2018;314:F1062\u201376.","journal-title":"Am J Physiol Renal Physiol"},{"key":"1013_CR68","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1074\/jbc.M110.149880","volume":"286","author":"A Renigunta","year":"2011","unstructured":"Renigunta A, Renigunta V, Saritas T, Decher N, Mutig K, Waldegger S. Tamm-Horsfall glycoprotein interacts with renal outer medullary potassium channel ROMK2 and regulates its function. J Biol Chem. 2011;286:2224\u201335.","journal-title":"J Biol Chem"},{"key":"1013_CR69","doi-asserted-by":"crossref","first-page":"F849","DOI":"10.1152\/ajprenal.00181.2009","volume":"297","author":"PA Welling","year":"2009","unstructured":"Welling PA, Ho K. A comprehensive guide to the ROMK potassium channel: form and function in health and disease. Am J Physiol-Renal Physiol. 2009;297:F849\u201363.","journal-title":"Am J Physiol-Renal Physiol"},{"key":"1013_CR70","doi-asserted-by":"crossref","first-page":"9410","DOI":"10.3390\/ijms23169410","volume":"23","author":"T Takata","year":"2022","unstructured":"Takata T, Hamada S, Mae Y, Iyama T, Ogihara R, Seno M, et al. Uromodulin regulates murine Aquaporin\u22122 activity via thick ascending limb\u2013collecting duct cross\u2212talk during water deprivation. IJMS. 2022;23:9410.","journal-title":"IJMS"},{"key":"1013_CR71","volume":"11","author":"C Chen","year":"2024","unstructured":"Chen C, Zhong W, Zheng H, Dai G, Zhao W, Wang Y, et al. The role of uromodulin in cardiovascular disease: a review. Front Cardiovasc Med. 2024;11:1417593.","journal-title":"Front Cardiovasc Med"},{"key":"1013_CR72","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1161\/HYPERTENSIONAHA.113.01423","volume":"63","author":"LA Graham","year":"2014","unstructured":"Graham LA, Padmanabhan S, Fraser NJ, Kumar S, Bates JM, Raffi HS, et al. Validation of uromodulin as a candidate gene for human essential hypertension. Hypertension. 2014;63:551\u20138.","journal-title":"Hypertension"},{"key":"1013_CR73","doi-asserted-by":"crossref","first-page":"F469","DOI":"10.1152\/ajprenal.00243.2010","volume":"299","author":"Y Liu","year":"2010","unstructured":"Liu Y, Mo L, Goldfarb DS, Evan AP, Liang F, Khan SR, et al. Progressive renal papillary calcification and ureteral stone formation in mice deficient for Tamm-Horsfall protein. Am J Physiol Renal Physiol. 2010;299:F469\u201378.","journal-title":"Am J Physiol Renal Physiol"},{"key":"1013_CR74","volume":"9","author":"E Olinger","year":"2019","unstructured":"Olinger E, Lake J, Sheehan S, Schiano G, Takata T, Tokonami N, et al. Hepsin-mediated processing of uromodulin is crucial for salt-sensitivity and thick ascending limb homeostasis. Sci Rep. 2019;9:12287.","journal-title":"Sci Rep"},{"key":"1013_CR75","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1046\/j.1523-1755.1998.00117.x","volume":"54","author":"WZ Ying","year":"1998","unstructured":"Ying WZ, Sanders PW. Dietary salt regulates expression of Tamm-Horsfall glycoprotein in rats. Kidney Int. 1998;54:1150\u20136.","journal-title":"Kidney Int"},{"key":"1013_CR76","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1042\/CS20211017","volume":"135","author":"S Mary","year":"2021","unstructured":"Mary S, Boder P, Rossitto G, Graham L, Scott K, Flynn A, et al. Salt loading decreases urinary excretion and increases intracellular accumulation of uromodulin in stroke-prone spontaneously hypertensive rats. Clin Sci. 2021;135:2749\u201361.","journal-title":"Clin Sci"},{"key":"1013_CR77","doi-asserted-by":"crossref","first-page":"p31","DOI":"10.1159\/000077600","volume":"97","author":"O Torffvit","year":"2004","unstructured":"Torffvit O, Melander O, Hult\u00e9n UL. Urinary excretion rate of tamm-horsfall protein is related to salt intake in humans. Nephron Physiol. 2004;97:p31\u20136.","journal-title":"Nephron Physiol"},{"key":"1013_CR78","doi-asserted-by":"crossref","first-page":"70","DOI":"10.2215\/CJN.04230415","volume":"11","author":"M Pruijm","year":"2016","unstructured":"Pruijm M, Ponte B, Ackermann D, Paccaud F, Guessous I, Ehret G, et al. Associations of urinary uromodulin with clinical characteristics and markers of tubular function in the general population. Clin J Am Soc Nephrol. 2016;11:70\u201380.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1013_CR79","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/hr.2012.51","volume":"35","author":"J Han","year":"2012","unstructured":"Han J, Chen Y, Liu Y, Liang Y, Wang X, Liu L, et al. Common variants of the UMOD promoter associated with blood pressure in a community-based Chinese cohort. Hypertens Res. 2012;35:769\u201374.","journal-title":"Hypertens Res"},{"key":"1013_CR80","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1016\/j.ekir.2022.05.011","volume":"7","author":"EA Akwo","year":"2022","unstructured":"Akwo EA, Chen HC, Liu G, Triozzi JL, Tao R, Yu Z, et al. Phenome-Wide Association Study of UMOD gene variants and differential associations with clinical outcomes across populations in the million veteran program a multiethnic biobank. Kidney Int Rep. 2022;7:1802\u201318.","journal-title":"Kidney Int Rep"},{"key":"1013_CR81","volume":"32","author":"S Prudente","year":"2016","unstructured":"Prudente S, Di Paola R, Copetti M, Lucchesi D, Lamacchia O, Pezzilli S, et al. The rs12917707 polymorphism at the UMOD locus and glomerular filtration rate in individuals with type 2 diabetes: evidence of heterogeneity across two different European populations. Nephrol Dial Transplant. 2016;32:gfw262.","journal-title":"Nephrol Dial Transplant"},{"key":"1013_CR82","volume":"8","author":"Y Wang","year":"2021","unstructured":"Wang Y, Du MF, Yao S, Zou T, Zhang XY, Hu GL, et al. Associations of serum uromodulin and its genetic variants with blood pressure and hypertension in chinese adults. Front Cardiovasc Med. 2021;8:710023.","journal-title":"Front Cardiovasc Med"},{"key":"1013_CR83","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1111\/jch.14347","volume":"23","author":"M Du","year":"2021","unstructured":"Du M, Yao S, Zou T, Mu J, Zhang X, Hu G, et al. Associations of plasma uromodulin and genetic variants with blood pressure responses to dietary salt interventions. J Clin Hypertens. 2021;23:1897\u2013906.","journal-title":"J Clin Hypertens"},{"key":"1013_CR84","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1681\/ASN.2016010098","volume":"27","author":"P Sekula","year":"2016","unstructured":"Sekula P, Del Greco MF, Pattaro C, K\u00f6ttgen A. Mendelian randomization as an approach to assess causality using observational data. JASN. 2016;27:3253\u201365.","journal-title":"JASN"},{"key":"1013_CR85","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1001\/jama.2017.17219","volume":"318","author":"CA Emdin","year":"2017","unstructured":"Emdin CA, Khera AV, Kathiresan S. Mendelian randomization. JAMA. 2017;318:1925.","journal-title":"JAMA"},{"key":"1013_CR86","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/s41431-022-01038-5","volume":"30","author":"C De Leeuw","year":"2022","unstructured":"De Leeuw C, Savage J, Bucur IG, Heskes T, Posthuma D. Understanding the assumptions underlying Mendelian randomization. Eur J Hum Genet. 2022;30:653\u201360.","journal-title":"Eur J Hum Genet"},{"key":"1013_CR87","doi-asserted-by":"crossref","first-page":"186","DOI":"10.12688\/wellcomeopenres.15555.3","volume":"4","author":"S Burgess","year":"2023","unstructured":"Burgess S, Davey Smith G, Davies NM, Dudbridge F, Gill D, Glymour MM, et al. Guidelines for performing Mendelian randomization investigations: update for summer 2023. Wellcome Open Res. 2023;4:186.","journal-title":"Wellcome Open Res"},{"key":"1013_CR88","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.kint.2021.08.032","volume":"100","author":"B Ponte","year":"2021","unstructured":"Ponte B, Sadler MC, Olinger E, Vollenweider P, Bochud M, Padmanabhan S, et al. Mendelian randomization to assess causality between uromodulin, blood pressure and chronic kidney disease. Kidney Int. 2021;100:1282\u201391.","journal-title":"Kidney Int"},{"key":"1013_CR89","volume":"8","author":"R You","year":"2021","unstructured":"You R, Chen L, Xu L, Zhang D, Li H, Shi X, et al. High level of uromodulin increases the risk of hypertension: a Mendelian Randomization Study. Front Cardiovasc Med. 2021;8:736001.","journal-title":"Front Cardiovasc Med"},{"key":"1013_CR90","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1161\/HYPERTENSIONAHA.122.19670","volume":"79","author":"Z Jian","year":"2022","unstructured":"Jian Z, Yuan C, Ma Y. Blood pressure mediated the effects of urinary uromodulin levels on myocardial infarction: a Mendelian Randomization Study. Hypertension. 2022;79:2430\u20138.","journal-title":"Hypertension"},{"key":"1013_CR91","doi-asserted-by":"crossref","first-page":"787","DOI":"10.2215\/CJN.11230720","volume":"16","author":"B Ponte","year":"2021","unstructured":"Ponte B, Pruijm M, Ackermann D, Olinger E, Youhanna S, Vogt B, et al. Uromodulin, salt, and 24-hour blood pressure in the general population. Clin J Am Soc Nephrol. 2021;16:787\u20139.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1013_CR92","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.2215\/CJN.0000000000000202","volume":"18","author":"KA LaFavers","year":"2023","unstructured":"LaFavers KA, Gaddy AR, Micanovic R, Lingeman J, Williams JC, Coe FL, et al. Water loading and uromodulin secretion in healthy individuals and idiopathic calcium stone formers. Clin J Am Soc Nephrol. 2023;18:1059\u201367.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1013_CR93","first-page":"212","volume":"88","author":"J Du\u0142awa","year":"1992","unstructured":"Du\u0142awa J, Kokot M, Kokot F. [Effects of furosemide, propranolol and nifedipine on urinary excretion of Tamm-Horsfall protein in patients with arterial hypertension]. Pol Arch Med Wewn. 1992;88:212\u20138.","journal-title":"Pol Arch Med Wewn"},{"key":"1013_CR94","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/sj.jhh.1000680","volume":"12","author":"J Du\u0142awa","year":"1998","unstructured":"Du\u0142awa J, Kokot F, Kokot M, Pander H. Urinary excretion of Tamm\u2013Horsfall protein in normotensive and hypertensive elderly patients. J Hum Hypertens. 1998;12:635\u20137.","journal-title":"J Hum Hypertens"},{"key":"1013_CR95","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.bbacli.2014.10.001","volume":"2","author":"V Matafora","year":"2014","unstructured":"Matafora V, Zagato L, Ferrandi M, Molinari I, Zerbini G, Casamassima N, et al. Quantitative proteomics reveals novel therapeutic and diagnostic markers in hypertension. BBA Clin. 2014;2:79\u201387.","journal-title":"BBA Clin"},{"key":"1013_CR96","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s40620-020-00877-z","volume":"34","author":"V Matafora","year":"2021","unstructured":"Matafora V, Lanzani C, Zagato L, Manunta P, Zacchia M, Trepiccione F, et al. Urinary proteomics reveals key markers of salt sensitivity in hypertensive patients during saline infusion. J Nephrol. 2021;34:739\u201351.","journal-title":"J Nephrol"},{"key":"1013_CR97","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/ajh\/hpaa140","volume":"34","author":"CY Bakhoum","year":"2021","unstructured":"Bakhoum CY, Anderson CAM, Juraschek SP, Rebholz CM, Appel LJ, Miller ER, et al. The relationship between urine uromodulin and blood pressure changes: the DASH-sodium trial. Am J Hypertens. 2021;34:154\u20136.","journal-title":"Am J Hypertens"},{"key":"1013_CR98","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/ajh\/hpaa166","volume":"34","author":"L McCallum","year":"2021","unstructured":"McCallum L, Brooksbank K, McConnachie A, Aman A, Lip S, Dawson J, et al. Rationale and design of the genotype-blinded trial of torasemide for the treatment of hypertension (BHF UMOD). Am J Hypertens. 2021;34:92\u20139.","journal-title":"Am J Hypertens"},{"key":"1013_CR99","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1161\/HYPERTENSIONAHA.124.23122","volume":"81","author":"L McCallum","year":"2024","unstructured":"McCallum L, Lip S, McConnachie A, Brooksbank K, MacIntyre I, Doney A, et al. UMOD genotype-blinded trial of ambulatory blood pressure response to torasemide. Hypertension. 2024;81:2049\u201359.","journal-title":"Hypertension"},{"key":"1013_CR100","first-page":"313","volume":"62","author":"J Josipovi\u0107","year":"2023","unstructured":"Josipovi\u0107 J. Uromodulin \u2013 a link between sodium excretion and alteration in circadian blood pressure pattern in prehypertensives. ACC. 2023;62:313\u201322.","journal-title":"ACC"},{"key":"1013_CR101","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1161\/HYPERTENSIONAHA.122.19566","volume":"79","author":"CY Bakhoum","year":"2022","unstructured":"Bakhoum CY, Matheson MB, Greenberg JH, Furth SL, Ix JH, Garimella PS. Urine uromodulin is not associated with blood pressure in the chronic kidney disease in children cohort. Hypertension. 2022;79:2298\u2013304.","journal-title":"Hypertension"},{"key":"1013_CR102","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1159\/000534578","volume":"148","author":"AL Bullen","year":"2024","unstructured":"Bullen AL, Vaingankar S, Madero M, Lopez Gil S, Macedo E, Ix JH, et al. Urine uromodulin, kidney tubulointerstitial fibrosis, and furosemide response. Nephron. 2024;148:443\u20137.","journal-title":"Nephron"},{"key":"1013_CR103","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.2215\/CJN.03600318","volume":"13","author":"E Pivin","year":"2018","unstructured":"Pivin E, Ponte B, De Seigneux S, Ackermann D, Guessous I, Ehret G, et al. Uromodulin and nephron mass. CJASN. 2018;13:1556\u20137.","journal-title":"CJASN"}],"container-title":["Journal of Human Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41371-025-01013-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41371-025-01013-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41371-025-01013-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T08:51:30Z","timestamp":1747039890000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41371-025-01013-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,31]]},"references-count":103,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["1013"],"URL":"https:\/\/doi.org\/10.1038\/s41371-025-01013-9","relation":{},"ISSN":["1476-5527"],"issn-type":[{"value":"1476-5527","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,31]]},"assertion":[{"value":"13 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"AO has received grants from Sanofi and consultancy or speaker fees or travel support from Adviccene, Alexion, Astellas, Astrazeneca, Amicus, Amgen, Bioporto, Boehringer Ingelheim, Esteve, Fresenius Medical Care, GSK, Bayer, Sanofi-Genzyme, Sobi, Menarini, Mundipharma, Kyowa Kirin, Lilly, Freeline, Idorsia, Chiesi, Otsuka, Novo-Nordisk, Sysmex and Vifor Fresenius Medical Care Renal Pharma and Spafarma and is Director of the Catedra UAM-Astrazeneca of chronic kidney disease and electrolytes. He has stock in Telara Farma. All of the other authors disclose that they do not have any financial or other relationships, which might lead to a conflict of interest regarding this paper.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}